forecast
AI Mainly Helps Downstream Clinical Development
Alex is short-term pessimistic and long-term optimistic about AI for drug discovery, and he expects AI to help in the near term with downstream tasks such as regulatory documents, market analysis, and trial enrollment rather than with molecular design itself.
forecastpending
Speaker
AlexEvidence Quote
“I'm much more optimistic about using AI in the short term to help drugs get to market faster”
Source
Alex Telford - Unlocking Innovation in Pharma - [Invest Like the Best, EP.360]— Invest Like the BestCreated: 11/14/2026, 6:42:06 AM
Your notes
Loading notes...